Cargando…
Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practice
BACKGROUND: New drugs for locally advanced or metastatic breast cancer have led to clinical benefits, aside with increasing costs to healthcare systems. The current financing model for health technology assessment (HTA) privileges real-world data. As part of the ongoing HTA, this study aimed to eval...
Autores principales: | Alves da Costa, Filipa, Cardoso Borges, Fábio, Ramos, Adriana, Mayer, Alexandra, Brito, Claudia, Ramos, Catarina, Bernardo, Catarina, Cossito, Mariane, Furtado, Cláudia, Ferreira, Arlindo R., Martins-Branco, Diogo, da Costa Miranda, Ana, Lourenço, António |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308630/ https://www.ncbi.nlm.nih.gov/pubmed/37386484 http://dx.doi.org/10.1186/s13058-023-01678-5 |
Ejemplares similares
-
Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study
por: Cardoso Borges, Fábio, et al.
Publicado: (2022) -
Epidemiological and clinical characterization of a population-based cohort of cutaneous malignant melanoma patients in the South Region of Portugal
por: Alves da Costa, Filipa, et al.
Publicado: (2023) -
Management of clinical relevant drug-drug interactions with antipsychotics in nursing homes
por: Bernardo, Catarina, et al.
Publicado: (2021) -
Pseudoprogression After Palbociclib with Aromatase Inhibitors Treatment in Metastatic Breast Cancer
por: Huang, Weiwei, et al.
Publicado: (2020) -
The South Region Cancer Registry: an evaluation of its exhaustiveness in a cohort of lung cancer patients
por: Verdasca, Jessica, et al.
Publicado: (2018)